Raman Bahal
Associate Professor/Pharmaceutical Science
Storrs Mansfield
Are you Raman Bahal?
How to update your information.
Scholarly Contributions
69 Scholarly Contributions
Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids.
2020
Research Type: Journal Article
Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis.
2019
Research Type: Journal Article
Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
2022
Research Type: Journal Article
In utero nanoparticle delivery for site-specific genome editing.
2018
Research Type: Journal Article
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery.
2016
Research Type: Journal Article
Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro.
2019
Research Type: Journal Article
Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
2020
Research Type: Journal Article
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
2015
Research Type: Journal Article
Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice.
2020
Research Type: Journal Article
Microrna-33 inhibitors and use thereof in the treatment of pulmonary fibrosis” Provisional patent
2022
Research Type: Patent and Intellectual Property
Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.
2015
Research Type: Journal Article
Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
2023
Research Type: Journal Article
Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.
2013
Research Type: Journal Article
Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids.
2022
Research Type: Journal Article
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.
2019
Research Type: Journal Article
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium.
2015
Research Type: Journal Article